Skip to main content
. 2019 Sep 9;134(17):1415–1429. doi: 10.1182/blood.2019001398

Table 1.

Patient characteristics

Baseline characteristic MSC sample population (n = 70) Not in MSC sample population (n = 585) P*
Age, median (range) 43.0 (22-65) 46.0 (23-65) .068
Sex
 Male 48 (68.6) 310 (53.0) .013
 Female 22 (31.4) 275 (47.0)
Baseline WBC, median (range) 11.0 (0.8-583.1) 7.9 (0.11-889.6) .24
PH status
 PH 51 (73.9) 392 (68.7) .37
 PH+ 18 (26.1) 179 (31.3)
 Missing/failed 1 14
T(4,11)
 Absent 62 (91.2) 497 (92.4) .33
 Present 6 (8.8) 41 (7.6)
 Missing/failed 2 47
Complexity
 Absent 53 (96.4) 425 (95.1) .97
 Present 2 (3.6) 22 (4.9)
 Missing/failed 15 138
HoTr/near-haploidy
 Absent 55 (96.5) 409 (89.7) .10
 Present 2 (3.5) 47 (10.3)
 Missing/failed 13 129
Any cytogenetic risk factors
 Absent 28 (50.0) 186 (39.6) .13
 Present 28 (50.0) 284 (60.4)
 Missing/failed 14 115
High-risk baseline
 Standard risk 13 (19.4) 64 (11.5) .064
 High risk 54 (80.6) 492 (88.5)
 Unknown, assumed standard 13 (19.4) 64 (11.5) .064

Data are expressed as n (%), unless otherwise stated.

HoTr, low hypodiploid/near triploidy; PH, Philadelphia chromosome; t4;11, presence of KMT2A/AFF1 rearrangement; WBC, white blood cell.

*

χ2, unless otherwise stated.

Wilcoxon Mann-Whitney test.

Fisher’s exact test.